Sugi Predict

Sugi Predict / Compounds / SCHEMBL10180979

SCHEMBL10180979

SCHEMBL10180979

CCN(CC)S(=O)(=O)C(F)(F)F

nearest known ligand 0.33

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.33
▸ HTT P42858 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ ABCC9 O60706 1/20 0.33
▸ ABCC8 Q09428 1/20 0.33
▸ KCNJ11 Q14654 1/20 0.33
▸ KCNJ8 Q15842 1/20 0.33
▸ CA1 P00915 2/20 0.32
▸ CA2 P00918 1/20 0.32
▸ CA7 P43166 1/20 0.32
▸ CA13 Q8N1Q1 1/20 0.32
▸ EPHX1 P07099 1/20 0.31
▸ NPC1 O15118 1/20 0.30
▸ RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12891812 0.81 ABCC9 (0.36) LMNAHTTSMN1; SMN2ABCC9ABCC8
SCHEMBL11362777 0.80 RAB9A (0.33) RAB9A
SCHEMBL31126318 0.79 CA1 (0.52) LMNASMN1; SMN2ABCC9ABCC8KCNJ11
SCHEMBL13871151 0.79 MLYCD (0.36) —
SCHEMBL2204176 0.78 CA1 (0.32) CA1CA2CA7CA13EPHX1
SCHEMBL22802244 0.77 CA1 (0.30) CA1
SCHEMBL19169870 0.76 MEN1 (0.33) HTT
SCHEMBL10198481 0.76 CA1 (0.30) CA1CA2CA7CA13EPHX1
SCHEMBL1319470 0.75 EPHX1 (0.39) CA1CA2EPHX1
SCHEMBL9609278 0.75 ABCC9 (0.33) HTTSMN1; SMN2ABCC9ABCC8KCNJ11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025049222-A1 ELECTROLYTE COMPRISING CYCLIC QUATERNARY AMMONIUM IONIC LIQUID AND SOLVENT WITH HIGH BOILING POINT AND BATTERIES COMPRISING SAME FACTORIAL INC. (US) 2025-03-06 — — WO claimed
WO-2025049220-A1 ELECTROLYTE COMPRISING IMIDAZOLIUM IONIC LIQUID AND SOLVENT WITH HIGH BOILING POINT AND BATTERIES COMPRISING SAME FACTORIAL INC. (US) 2025-03-06 — — WO claimed
WO-2025024654-A2 SCALABLE PROCESS FOR MANUFACTURING TRIFLUOROSULFONAMIDES MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2025-01-30 — — WO claimed
EP-4444695-A1 PROCESSES FOR PRODUCING HIGH-PURITY N, N-DIALKYL PERFLUOROALKYL SULFONAMIDE SES Holdings Pte. Ltd. (SG) 2024-10-16 — — EP claimed
WO-2024198675-A1 SODIUM-ION BATTERY ELECTROLYTE AND SODIUM-ION BATTERY 杭州菲科技术创新有限公司 2024-10-03 — — WO claimed
WO-2024196936-A2 LOCALIZED HIGH CONCENTRATION ELECTROLYTE AND LITHIUM-ION BATTERY COMPRISING THE SAME SILA NANOTECHNOLOGIES, INC. (US) 2024-09-26 — — WO claimed
US-20240322244-A1 LOCALIZED HIGH CONCENTRATION ELECTROLYTE AND LITHIUM-ION BATTERY COMPRISING THE SAME SILA NANOTECHNOLOGIES, INC. 2024-09-26 — — US claimed
CN-118354997-A Process for producing high purity N, N-dialkyl perfluoroalkyl sulfonamides 麻省固能控股有限公司 2024-07-16 — — CN claimed
CN-116315071-A Wide-temperature solid electrolyte 上海交通大学绍兴新能源与分子工程研究院 2023-06-23 — — CN claimed
US-11680041-B1 Processes for producing high-purity N,N-dialkyl perfluoroalkylsulfonamide SES HOLDINGS PTE. LTD. (SG) 2023-06-20 — — US claimed
WO-2023105411-A1 PROCESSES FOR PRODUCING HIGH-PURITY N, N-DIALKYL PERFLUOROALKYL SULFONAMIDE SES HOLDINGS PTE. LTD. (SG) 2023-06-15 — — WO claimed
US-20230174469-A1 Processes For Producing High-Purity N,N-Dialkyl Perfluoroalkylsulfonamide SES HOLDINGS PTE. LTD. (SG) 2023-06-08 — — US claimed
US-12438196-B2 Electrolytes for lithium batteries SION POWER CORPORATION (US) 2025-10-07 — — US disclosed
WO-2025129749-A1 NEGATIVE ELECTRODE SHEET, BATTERY, PREPARATION METHOD, AND USE 惠州锂威新能源科技有限公司 2025-06-26 — — WO disclosed
WO-2025049220-A1 ELECTROLYTE COMPRISING IMIDAZOLIUM IONIC LIQUID AND SOLVENT WITH HIGH BOILING POINT AND BATTERIES COMPRISING SAME FACTORIAL INC. (US) 2025-03-06 — — WO disclosed
WO-2025049222-A1 ELECTROLYTE COMPRISING CYCLIC QUATERNARY AMMONIUM IONIC LIQUID AND SOLVENT WITH HIGH BOILING POINT AND BATTERIES COMPRISING SAME FACTORIAL INC. (US) 2025-03-06 — — WO disclosed
US-20150004481-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY MITSUBISHI CHEMICAL CORPORATION (JP) 2015-01-01 — — US disclosed
US-20130244122-A1 NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS-ELECTROLYTE BATTERY EMPLOYING THE SAME ONUKI MASAMICHI (JP) 2013-09-19 — — US disclosed
US-20120219866-A1 NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS-ELECTROLYTE BATTERY EMPLOYING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2012-08-30 — — US disclosed
EP-2475041-A1 NON-AQUEOUS ELECTROLYTIC SOLUTION, AND NON-AQUEOUS ELECTROLYTE BATTERY COMPRISING SAME Mitsubishi Chemical Corporation (JP) 2012-07-11 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11680041-B1 Processes for producing high-purity N,N-dialkyl perfluoroalkylsulfonamide RFC2, AFF2, AFF1 LMNA 261/4885HTT 568/4885SMN1; SMN2 833/4885
US-20230174469-A1 Processes For Producing High-Purity N,N-Dialkyl Perfluoroalkylsulfonamide RFC2, AFF2, AFF1 LMNA 261/4885HTT 568/4885SMN1; SMN2 833/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.